Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
NCT ID: NCT00920179
Last Updated: 2009-06-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
30 participants
OBSERVATIONAL
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Superb Microvascular Imaging Ultrasonography of Lacrimal Gland in Patients With Sjögren Syndrome
NCT05689749
Differential Diagnosis of Sjögren's Versus Non-Sjögren's Dry Eye
NCT04493658
Efficacy of 0.05% Cyclosporine A Eye Drops Combined With Absorbable Tear Duct Plugs in the Treatment of Dry Eye in Sjögren's Syndrom
NCT07171710
CXCL9, CXCL10, CXCL11, and CXCR3 in Dry Eye Syndrome
NCT00991679
Analysis of the Diagnostic Performance of LacryDiag, a New Analyzer of the Ocular Surface in the Dry Eye
NCT04093037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dry eye group
Dry eye patients with Primary Sjogren's syndrome
No interventions assigned to this group
Controls
Healthy subjects without dry eyes
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Briefly, the patients had to have ocular and oral symptoms of dryness,
* clinically diagnosed dry eye and dry mouth disease,
* serum rheumatoid factor and antinuclear antibody levels ≥1:160,
* positive serology for anti SS-A or anti SS-B antibodies,
* labial salivary gland inflammatory infiltration focus score ≥2 and consents for lacrimal gland biopsy to be included into this study.
Exclusion Criteria
* other ocular or systemic disease
* or a history of topical/ systemic drug use or contact lens wear or
* other systemic disorders that would cause dry eyes or that would alter the ocular surface.
20 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Keio University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
J&J Ocular Surface and Visual Optics Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kazuo Tsubota, Professor
Role: STUDY_DIRECTOR
Keio University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Keio University School of Medicine
Tokyo, , Japan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
21071965
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.